MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 287 filers reported holding MYRIAD GENETICS INC in Q1 2014. The put-call ratio across all filers is 2.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $201,000 | -74.7% | 10,545 | -61.4% | 0.04% | -81.5% |
| Q4 2018 | $794,000 | -18.7% | 27,297 | +28.6% | 0.19% | -1.6% |
| Q3 2018 | $977,000 | +23.2% | 21,230 | 0.0% | 0.19% | +18.5% |
| Q2 2018 | $793,000 | +71.6% | 21,230 | +35.8% | 0.16% | +65.3% |
| Q1 2018 | $462,000 | -58.6% | 15,630 | -45.5% | 0.10% | -19.7% |
| Q2 2014 | $1,117,000 | – | 28,700 | +286900.0% | 0.12% | – |
| Q4 2013 | $0 | -100.0% | 10 | -100.0% | 0.00% | -100.0% |
| Q3 2013 | $4,069,000 | -14.4% | 173,173 | -2.1% | 0.52% | -19.9% |
| Q2 2013 | $4,754,000 | – | 176,938 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |